Daigo Hashimoto

20PUBLICATIONS
88CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 24, 2026
Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

|Feb 13, 2026
Recent advances in the pathophysiology of acute and chronic graft-versus-host disease.

Shuichiro Takahashi, Daigo Hashimoto

|Aug 22, 2025
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.

Nirav N Shah, Pier Luigi Zinzani, Michael Wang

|Jun 12, 2025
TET3 stirs up trouble via pathogenic Ig class switching.

Daigo Hashimoto

|Jun 21, 2024
GVHD targets organoid-forming bile duct stem cells in a TGF-β-dependent manner.

Yuta Hasegawa, Daigo Hashimoto, Zixuan Zhang

|May 22, 2023
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.

Hajime Senjo, Shinpei Harada, Shimpei I Kubota

Pageof 4

Frequent Collaborators

14 joint publications

Takanori Teshima

6 joint publications

Yuta Hasegawa

6 joint publications

Takahide Ara

5 joint publications

Shuichiro Takahashi